A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
Status:
Completed
Trial end date:
2019-03-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of omalizumab compared with
placebo in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP) who have
had an inadequate response to standard-of-care treatments.
Study GA39855 (POLYP 2; NCT03280537) was another Phase III study by the Sponsor with
identical objectives and design and was run in parallel with this study.